151751-Najiba-Chargi

409 The elderly head and neck cancer patient: skeletal muscle mass and frailty Table 2.1. (Continued) Total Sarcopenic Non sarcopenic χ 2 p-value N=73 N=24 N=49 Age (years) (M, SD) 81.73 6.24(SD) 83.7 5.73(SD) 80.24 6.21(SD) NA 0.03 Paranasal sinuses 2 2 1 4 2 4 Type of tumor (n, %) Primary 56 77 17 71 39 80 1.02 0.60 Recurrent 11 15 4 17 7 14 Second primary 6 8 3 13 3 6 TNM Stage (n, %) I 8 11 5 21 3 6 3.71 0.30 II 19 26 5 21 14 29 III 14 19 4 17 10 20 IV 32 44 10 42 22 45 Low Muscle strength (n, %) No 40 55 0 0 40 82 43.34 0.000 Yes 33 45 24 100 9 18 Low SMI (n, %) No 15 21 0 0 15 31 9.26 0.002 Yes 58 79 24 100 34 69 Frailty Fried criteria (n, %) No 52 71 10 42 42 86 15.25 0.000 Yes 21 29 14 58 7 14 Frailty GFI (n, %) No 35 50 9 38 26 53 1.56 0.21 Yes 38 52 15 63 23 47 Frailty CGA (n, %) No 34 46 7 29 27 55 4.36 0.04 Yes 39 54 17 71 22 45 BMI= Body Mass Index. MUST= Malnutrition Universal Screening Tool. SMI= Skeletal Muscle Index. GFI= Groningen Frailty Indicator. CGA= Comprehensive Geriatric Assessment. CORRELATIONS Table 2.1 shows statistically significant differences in CGA, Fried criteria, age at diagnosis, and BMI between patients with and without sarcopenia. Patients with sarcopenia were more likely to be frail according to the CGA (71% versus 45%; p<0.05) and the Fried criteria (58% versus 14%; p<0.00), to be older of age (mean 83.7 years versus 80.24 years; p<0.05), and to have a lower BMI at diagnosis (25.12 versus 27.92, p<0.05). Table 2.2 shows statistically signif - icant differences in sarcopenia, age at diagnosis, sex, low SMI, Fried criteria, and GFI between 20